nodes	percent_of_prediction	percent_of_DWPC	metapath
Mebendazole—ABCB1—Methylprednisolone—multiple sclerosis	0.0935	0.11	CbGbCtD
Mebendazole—CYP1A1—Dexamethasone—multiple sclerosis	0.0906	0.107	CbGbCtD
Mebendazole—CYP3A4—Fingolimod—multiple sclerosis	0.087	0.103	CbGbCtD
Mebendazole—ABCB1—Mitoxantrone—multiple sclerosis	0.0682	0.0805	CbGbCtD
Mebendazole—ABCB1—Betamethasone—multiple sclerosis	0.0608	0.0718	CbGbCtD
Mebendazole—ABCB1—Prednisolone—multiple sclerosis	0.06	0.0708	CbGbCtD
Mebendazole—ABCB1—Prednisone—multiple sclerosis	0.0567	0.0669	CbGbCtD
Mebendazole—CYP3A4—Methylprednisolone—multiple sclerosis	0.056	0.0661	CbGbCtD
Mebendazole—CYP3A4—Triamcinolone—multiple sclerosis	0.0425	0.0501	CbGbCtD
Mebendazole—CYP3A4—Mitoxantrone—multiple sclerosis	0.0409	0.0482	CbGbCtD
Mebendazole—CYP3A4—Betamethasone—multiple sclerosis	0.0364	0.043	CbGbCtD
Mebendazole—CYP3A4—Prednisolone—multiple sclerosis	0.036	0.0424	CbGbCtD
Mebendazole—ABCB1—Dexamethasone—multiple sclerosis	0.0354	0.0417	CbGbCtD
Mebendazole—CYP3A4—Prednisone—multiple sclerosis	0.034	0.0401	CbGbCtD
Mebendazole—ABCB1—Methotrexate—multiple sclerosis	0.0284	0.0335	CbGbCtD
Mebendazole—TUBA1A—pons—multiple sclerosis	0.0274	0.188	CbGeAlD
Mebendazole—CYP3A4—Dexamethasone—multiple sclerosis	0.0212	0.025	CbGbCtD
Mebendazole—TUBA1A—pineal body—multiple sclerosis	0.0195	0.134	CbGeAlD
Mebendazole—TUBA1A—peripheral nervous system—multiple sclerosis	0.0182	0.125	CbGeAlD
Mebendazole—TUBA1A—nerve—multiple sclerosis	0.0142	0.0977	CbGeAlD
Mebendazole—TUBA1A—brainstem—multiple sclerosis	0.00609	0.0419	CbGeAlD
Mebendazole—TUBA1A—retina—multiple sclerosis	0.00588	0.0405	CbGeAlD
Mebendazole—TUBA1A—Azacitidine—Cladribine—multiple sclerosis	0.00554	1	CbGdCrCtD
Mebendazole—TUBA1A—medulla oblongata—multiple sclerosis	0.00425	0.0292	CbGeAlD
Mebendazole—TUBB4B—retina—multiple sclerosis	0.00392	0.027	CbGeAlD
Mebendazole—TUBA1A—midbrain—multiple sclerosis	0.00388	0.0267	CbGeAlD
Mebendazole—TUBA1A—spinal cord—multiple sclerosis	0.00379	0.0261	CbGeAlD
Mebendazole—TUBA1A—nervous system—multiple sclerosis	0.00319	0.022	CbGeAlD
Mebendazole—TUBA1A—central nervous system—multiple sclerosis	0.00307	0.0212	CbGeAlD
Mebendazole—TUBA1A—cerebellum—multiple sclerosis	0.003	0.0207	CbGeAlD
Mebendazole—TUBB4B—medulla oblongata—multiple sclerosis	0.00283	0.0195	CbGeAlD
Mebendazole—TUBB4B—midbrain—multiple sclerosis	0.00259	0.0178	CbGeAlD
Mebendazole—TUBB4B—spinal cord—multiple sclerosis	0.00253	0.0174	CbGeAlD
Mebendazole—TUBA1A—brain—multiple sclerosis	0.00244	0.0168	CbGeAlD
Mebendazole—TUBB4B—nervous system—multiple sclerosis	0.00213	0.0146	CbGeAlD
Mebendazole—TUBB4B—central nervous system—multiple sclerosis	0.00205	0.0141	CbGeAlD
Mebendazole—TUBB4B—cerebellum—multiple sclerosis	0.002	0.0138	CbGeAlD
Mebendazole—TUBB4B—brain—multiple sclerosis	0.00163	0.0112	CbGeAlD
Mebendazole—CYP1A1—nervous system—multiple sclerosis	0.00119	0.0082	CbGeAlD
Mebendazole—CYP1A1—central nervous system—multiple sclerosis	0.00115	0.0079	CbGeAlD
Mebendazole—ABCB1—retina—multiple sclerosis	0.00114	0.00784	CbGeAlD
Mebendazole—CYP1A1—brain—multiple sclerosis	0.000911	0.00627	CbGeAlD
Mebendazole—CYP3A4—nervous system—multiple sclerosis	0.000874	0.00602	CbGeAlD
Mebendazole—CYP3A4—central nervous system—multiple sclerosis	0.000842	0.00579	CbGeAlD
Mebendazole—ABCB1—medulla oblongata—multiple sclerosis	0.000824	0.00567	CbGeAlD
Mebendazole—ABCB1—midbrain—multiple sclerosis	0.000753	0.00518	CbGeAlD
Mebendazole—ABCB1—spinal cord—multiple sclerosis	0.000734	0.00506	CbGeAlD
Mebendazole—ABCB1—nervous system—multiple sclerosis	0.000619	0.00426	CbGeAlD
Mebendazole—ABCB1—central nervous system—multiple sclerosis	0.000596	0.0041	CbGeAlD
Mebendazole—ABCB1—cerebellum—multiple sclerosis	0.000582	0.00401	CbGeAlD
Mebendazole—ABCB1—brain—multiple sclerosis	0.000473	0.00326	CbGeAlD
Mebendazole—Menorrhagia—Mitoxantrone—multiple sclerosis	9.57e-05	0.0632	CcSEcCtD
Mebendazole—Neutropenia—Cladribine—multiple sclerosis	6.32e-05	0.0418	CcSEcCtD
Mebendazole—Agranulocytosis—Azathioprine—multiple sclerosis	4.57e-05	0.0302	CcSEcCtD
Mebendazole—Neutropenia—Mitoxantrone—multiple sclerosis	4.16e-05	0.0275	CcSEcCtD
Mebendazole—Agranulocytosis—Mitoxantrone—multiple sclerosis	3.7e-05	0.0244	CcSEcCtD
Mebendazole—Hepatitis—Mitoxantrone—multiple sclerosis	3.56e-05	0.0235	CcSEcCtD
Mebendazole—Gastrointestinal pain—Cladribine—multiple sclerosis	3.14e-05	0.0208	CcSEcCtD
Mebendazole—Urticaria—Cladribine—multiple sclerosis	3.05e-05	0.0202	CcSEcCtD
Mebendazole—Abdominal pain—Cladribine—multiple sclerosis	3.04e-05	0.0201	CcSEcCtD
Mebendazole—Hypersensitivity—Cladribine—multiple sclerosis	2.83e-05	0.0187	CcSEcCtD
Mebendazole—Convulsion—Mitoxantrone—multiple sclerosis	2.68e-05	0.0177	CcSEcCtD
Mebendazole—Gastrointestinal pain—Azathioprine—multiple sclerosis	2.56e-05	0.0169	CcSEcCtD
Mebendazole—Neutropenia—Prednisone—multiple sclerosis	2.48e-05	0.0164	CcSEcCtD
Mebendazole—Abdominal pain—Azathioprine—multiple sclerosis	2.47e-05	0.0163	CcSEcCtD
Mebendazole—Rash—Cladribine—multiple sclerosis	2.42e-05	0.016	CcSEcCtD
Mebendazole—Dermatitis—Cladribine—multiple sclerosis	2.42e-05	0.016	CcSEcCtD
Mebendazole—Angioedema—Prednisolone—multiple sclerosis	2.32e-05	0.0153	CcSEcCtD
Mebendazole—Hypersensitivity—Azathioprine—multiple sclerosis	2.3e-05	0.0152	CcSEcCtD
Mebendazole—Convulsion—Prednisolone—multiple sclerosis	2.2e-05	0.0145	CcSEcCtD
Mebendazole—Angioedema—Triamcinolone—multiple sclerosis	2.13e-05	0.0141	CcSEcCtD
Mebendazole—Angioedema—Methylprednisolone—multiple sclerosis	2.13e-05	0.0141	CcSEcCtD
Mebendazole—Neutropenia—Methotrexate—multiple sclerosis	2.07e-05	0.0137	CcSEcCtD
Mebendazole—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	2.07e-05	0.0137	CcSEcCtD
Mebendazole—Convulsion—Triamcinolone—multiple sclerosis	2.02e-05	0.0134	CcSEcCtD
Mebendazole—Convulsion—Methylprednisolone—multiple sclerosis	2.02e-05	0.0133	CcSEcCtD
Mebendazole—Urticaria—Mitoxantrone—multiple sclerosis	2.01e-05	0.0133	CcSEcCtD
Mebendazole—Abdominal pain—Mitoxantrone—multiple sclerosis	2e-05	0.0132	CcSEcCtD
Mebendazole—Rash—Azathioprine—multiple sclerosis	1.97e-05	0.013	CcSEcCtD
Mebendazole—Dermatitis—Azathioprine—multiple sclerosis	1.97e-05	0.013	CcSEcCtD
Mebendazole—Angioedema—Betamethasone—multiple sclerosis	1.94e-05	0.0128	CcSEcCtD
Mebendazole—Angioedema—Dexamethasone—multiple sclerosis	1.94e-05	0.0128	CcSEcCtD
Mebendazole—Hypersensitivity—Mitoxantrone—multiple sclerosis	1.86e-05	0.0123	CcSEcCtD
Mebendazole—Agranulocytosis—Methotrexate—multiple sclerosis	1.84e-05	0.0122	CcSEcCtD
Mebendazole—Convulsion—Betamethasone—multiple sclerosis	1.84e-05	0.0121	CcSEcCtD
Mebendazole—Convulsion—Dexamethasone—multiple sclerosis	1.84e-05	0.0121	CcSEcCtD
Mebendazole—Hepatitis—Methotrexate—multiple sclerosis	1.77e-05	0.0117	CcSEcCtD
Mebendazole—Angioedema—Prednisone—multiple sclerosis	1.69e-05	0.0111	CcSEcCtD
Mebendazole—Urticaria—Prednisolone—multiple sclerosis	1.65e-05	0.0109	CcSEcCtD
Mebendazole—Convulsion—Prednisone—multiple sclerosis	1.6e-05	0.0106	CcSEcCtD
Mebendazole—Rash—Mitoxantrone—multiple sclerosis	1.59e-05	0.0105	CcSEcCtD
Mebendazole—Dermatitis—Mitoxantrone—multiple sclerosis	1.59e-05	0.0105	CcSEcCtD
Mebendazole—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	1.56e-05	0.0103	CcSEcCtD
Mebendazole—Hypersensitivity—Prednisolone—multiple sclerosis	1.53e-05	0.0101	CcSEcCtD
Mebendazole—Urticaria—Triamcinolone—multiple sclerosis	1.51e-05	0.01	CcSEcCtD
Mebendazole—Urticaria—Methylprednisolone—multiple sclerosis	1.51e-05	0.00999	CcSEcCtD
Mebendazole—Abdominal pain—Methylprednisolone—multiple sclerosis	1.5e-05	0.00994	CcSEcCtD
Mebendazole—Gastrointestinal pain—Betamethasone—multiple sclerosis	1.41e-05	0.00935	CcSEcCtD
Mebendazole—Gastrointestinal pain—Dexamethasone—multiple sclerosis	1.41e-05	0.00935	CcSEcCtD
Mebendazole—Hypersensitivity—Triamcinolone—multiple sclerosis	1.4e-05	0.00928	CcSEcCtD
Mebendazole—Hypersensitivity—Methylprednisolone—multiple sclerosis	1.4e-05	0.00926	CcSEcCtD
Mebendazole—Urticaria—Dexamethasone—multiple sclerosis	1.37e-05	0.00908	CcSEcCtD
Mebendazole—Urticaria—Betamethasone—multiple sclerosis	1.37e-05	0.00908	CcSEcCtD
Mebendazole—Abdominal pain—Dexamethasone—multiple sclerosis	1.37e-05	0.00904	CcSEcCtD
Mebendazole—Abdominal pain—Betamethasone—multiple sclerosis	1.37e-05	0.00904	CcSEcCtD
Mebendazole—Convulsion—Methotrexate—multiple sclerosis	1.34e-05	0.00883	CcSEcCtD
Mebendazole—Rash—Prednisolone—multiple sclerosis	1.31e-05	0.00864	CcSEcCtD
Mebendazole—Dermatitis—Prednisolone—multiple sclerosis	1.31e-05	0.00863	CcSEcCtD
Mebendazole—Gastrointestinal pain—Prednisone—multiple sclerosis	1.23e-05	0.00814	CcSEcCtD
Mebendazole—Rash—Triamcinolone—multiple sclerosis	1.2e-05	0.00794	CcSEcCtD
Mebendazole—Dermatitis—Triamcinolone—multiple sclerosis	1.2e-05	0.00794	CcSEcCtD
Mebendazole—Rash—Methylprednisolone—multiple sclerosis	1.2e-05	0.00793	CcSEcCtD
Mebendazole—Dermatitis—Methylprednisolone—multiple sclerosis	1.2e-05	0.00792	CcSEcCtD
Mebendazole—Urticaria—Prednisone—multiple sclerosis	1.2e-05	0.00791	CcSEcCtD
Mebendazole—Abdominal pain—Prednisone—multiple sclerosis	1.19e-05	0.00787	CcSEcCtD
Mebendazole—Hypersensitivity—Prednisone—multiple sclerosis	1.11e-05	0.00733	CcSEcCtD
Mebendazole—Rash—Dexamethasone—multiple sclerosis	1.09e-05	0.00721	CcSEcCtD
Mebendazole—Rash—Betamethasone—multiple sclerosis	1.09e-05	0.00721	CcSEcCtD
Mebendazole—Dermatitis—Dexamethasone—multiple sclerosis	1.09e-05	0.0072	CcSEcCtD
Mebendazole—Dermatitis—Betamethasone—multiple sclerosis	1.09e-05	0.0072	CcSEcCtD
Mebendazole—Gastrointestinal pain—Methotrexate—multiple sclerosis	1.03e-05	0.0068	CcSEcCtD
Mebendazole—Urticaria—Methotrexate—multiple sclerosis	1e-05	0.00661	CcSEcCtD
Mebendazole—Abdominal pain—Methotrexate—multiple sclerosis	9.95e-06	0.00658	CcSEcCtD
Mebendazole—Rash—Prednisone—multiple sclerosis	9.5e-06	0.00628	CcSEcCtD
Mebendazole—Dermatitis—Prednisone—multiple sclerosis	9.49e-06	0.00627	CcSEcCtD
Mebendazole—Hypersensitivity—Methotrexate—multiple sclerosis	9.28e-06	0.00613	CcSEcCtD
Mebendazole—Rash—Methotrexate—multiple sclerosis	7.94e-06	0.00525	CcSEcCtD
Mebendazole—Dermatitis—Methotrexate—multiple sclerosis	7.93e-06	0.00524	CcSEcCtD
